SCHEMBL3302633

SCHEMBL3302633

CC(C)(C)c1cc(C(C)(C)C)c(C(C)(C)C)cc1[SiH](O[SiH](c1cc(C(C)(C)C)c(C(C)(C)C)cc1C(C)(C)C)c1cc(C(C)(C)C)c(C(C)(C)C)cc1C(C)(C)C)c1cc(C(C)(C)C)c(C(C)(C)C)cc1C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.35
CA1 P00915 2/20 0.35
ALOX15 P16050 2/20 0.33
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAPT P10636 1/20 0.33
ATP2A2 P16615 1/20 0.33
ATP2A3 Q93084 1/20 0.33
GLRA3 O75311 1/20 0.30
GLRB P48167 1/20 0.30
POLB P06746 1/20 0.30
TYR P14679 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3300217 0.76 CA1 (0.41) CA2CA1ALDH1A1SMN1; SMN2LMNA
SCHEMBL3296168 0.74 ALDH1A1 (0.38) CA2CA1ALOX15ALDH1A1SMN1; SMN2
SCHEMBL3297570 0.74 ALDH1A1 (0.38) CA2CA1ALOX15ALDH1A1LMNA
SCHEMBL3296284 0.73 CA1 (0.47) CA2CA1ALDH1A1SMN1; SMN2LMNA
SCHEMBL3295605 0.73 SHBG (0.34)
SCHEMBL7132801 0.72 ALDH1A1 (0.53) CA2CA1ALOX15ALDH1A1SMN1; SMN2
SCHEMBL3298464 0.70 ALDH1A1 (0.43) CA2ALDH1A1TP53KDM4ECYP1A2
SCHEMBL3296093 0.69 GABRA1 (0.31)
SCHEMBL3296192 0.68 ALDH1A1 (0.31) ALOX15ALDH1A1SMN1; SMN2LMNAKDM4E
SCHEMBL3297740 0.68 NQO1 (0.42) CA1ALDH1A1TP53CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 CA2 3413/4885CA1 2428/4885ALOX15 2238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.